Healthtech Investors & VC Firms in North America
2650 firms in this list, with a median first check of $500K. 645 of them lead rounds. Generated from verified public data and updated continuously.
Cowles Ventures
SpokaneSeed–Series A$250K – $1M
9 people
Gryphon
San Francisco
Iaso Ventures
CambridgeSeed–Series A
15 people
Wireframe Ventures
San FranciscoPre-Seed–Seed$500K – $2M
3 people
Cybernetix Ventures
BostonPre-Seed–Series A$60K – $500K
17 people
NVP Capital
New YorkPre-Seed–Seed$2M
8 people
Toronto Innovation Acceleration Partners
TorontoPre-Seed–Seed
11 people
VamosVentures
Los AngelesPre-Seed–Series A$2M
11 people
IU Ventures
BloomingtonSeed–Series A
1 person
Artisanal Ventures
TiburonSeed–Series A
7 people
Workshop Venture Partners
San FranciscoPre-Seed–Seed$3M
13 people
WMU Biosciences Research & Commercialization Center
KalamazooSeed–Series A$100K – $250K
12 people
Blue Tulip Ventures
BostonPre-Seed–Series A
23 people
Brightstone Venture Capital
MinneapolisSeed–Late Stage$250K – $10M
11 people
Cathay Capital
StamfordGrowth
11 people
BootstrapLabs
Silicon ValleySeed–Growth$100K – $6M
10 people
Cistern Capital
New YorkPre-Seed–Seed
19 people
Crew Capital
New YorkPre-Seed–Growth$500K – $2M
4 people
Mission Bay Capital
San FranciscoPre-Seed–Series A
13 people
One Planet Group
San FranciscoPre-Seed–Series A
4 people
Redesign Health
New YorkSeed–Late Stage
19 people
Amasia
BurlingameSeed–Series A$100K – $5M
12 people
Cloud Health Euroventures
NewarkPre-Seed–Series A$100K – $1M
21 people
Riverbend Capital
WashingtonPre-Seed–Late Stage
15 people
Related lists
Investors & VC Firms in North America (13488)Investors & VC Firms in United States (12527)Investors & VC Firms in Europe (5831)Investors & VC Firms in Global (4707)AI & Machine Learning Investors & VC Firms (4538)Fintech Investors & VC Firms (4530)SaaS Investors & VC Firms (4205)Healthtech Investors & VC Firms (4177)Enterprise Software Investors & VC Firms (4092)Crypto & Web3 Investors & VC Firms (3961)
Data sourced from public filings and firms' own websites — see our methodology.






























































































